Laser Treatment for Chemotherapy-Induced Peripheral Neuropathy Circle

Principal Investigator:

Dr. Kate Perkins

Study Abstract:

30-40% of patients, globally, receiving chemotherapy will experience Chemotherapy Induced Peripheral Neuropathy (CIPN) at some point during or after treatment. OncoLaser utilizes the MLS Laser to heal and reduce symptoms of CIPN. With the synchronization of two wavelengths, MLS therapy is one of the most advanced laser therapy systems available to the market today. This Circle is designed to help practitioners track their everyday patients’ personal outcomes and correlate against specific settings with the MLS Laser system. Members will be able to contribute to, and benefit from, a growing repository of Laser Therapy real-world data, and will have the ability to collaborate with experts in the field. Circle members will own all data collected and will have the ability to monetize this real-world data they collect every day.

Study Type:

Observational

Circle Benefits:
  • Engage patients in long-term outcomes reporting, leading to improved adherence and results.
  • Ownership of high-quality, real-world data with possibility of monetization and licensing.
  • Collaborate with Laser experts to benchmark your results and receive mentorship.
  • Get exposed to new, evidence-based techniques and treatment protocols for MLS Laser system.
Real-World Data Surveys:
  • Quality of Life Questionnaire- Chemotherapy Induced Neuropathy 20 (QLQ-CIPN 20)
  • Lower Extremity Functional Scale (LEFS)
Circle Type:
locked lock icon for private circles

Private Circle

Interested in learning more about this Circle?

Related Posts

No items found.
Additional Resources:

Laser Treatment for Chemotherapy-Induced Peripheral Neuropathy Circle

Circle Objective Abstract:

30-40% of patients, globally, receiving chemotherapy will experience Chemotherapy Induced Peripheral Neuropathy (CIPN) at some point during or after treatment. OncoLaser utilizes the MLS Laser to heal and reduce symptoms of CIPN. With the synchronization of two wavelengths, MLS therapy is one of the most advanced laser therapy systems available to the market today. This Circle is designed to help practitioners track their everyday patients’ personal outcomes and correlate against specific settings with the MLS Laser system. Members will be able to contribute to, and benefit from, a growing repository of Laser Therapy real-world data, and will have the ability to collaborate with experts in the field. Circle members will own all data collected and will have the ability to monetize this real-world data they collect every day.

Real-World Data Surveys:

QLQ-CIPN 20; LEFS

Intervention:

Circle Benefits:
  • Engage patients in long-term outcomes reporting, leading to improved adherence and results.
  • Ownership of high-quality, real-world data with possibility of monetization and licensing.
  • Collaborate with Laser experts to benchmark your results and receive mentorship.
  • Get exposed to new, evidence-based techniques and treatment protocols for MLS Laser system.

Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration

Circle Type:
locked lock icon for private circles

Private Circle

Supporting Materials
Interested in learning more about this Circle?

CIRCLE LIBRARY

CIRCLE NAME

Total Knee Arthroplasty Outcome-Based Performance Measure

SURVEYS

OUTCOMES SURVEYS

VAS
KOOS Jr.
VR-12 (compliant with CMS/IQR Requirements)

CLINICAL SURVEYS

As specified by Provider

THIS CIRCLE IS FOR:

Provider Receiving CMS Reimbursement For TKAs

CMS will soon penalize providers performing total knee replacements which do not collect specified outcomes data from at least 50% of qualifying patients.

Other Providers Performing TKAs

Private insurance companies and other payers within and outside the U.S. will follow the CMS lead in requiring high patient compliance in reporting long-term TKA outcomes.

WHY CIRCLES

Patented technology
HIPAA, GDPR, GCP and Part 11 compliant
Multilingual
Scalable
Easily export to, integrate with, existing systems
Robust reporting functions
Illustrative Materials
Minimal administrative and clinical burden
Accommodates surgical variations
All data accessible 24/7 from any device
Allows extensive customization
Inherent collaboration among peers
Improves clinical decision-making
Adjustable outcomes alerts
Regular reports on key metrics
Automatic patient consent capture
Illustrative Materials
Sustained onboarding and follow-up processes
Communication of condition and protocol education materials *
Regular progress reports *
Cohort comparisons *
Newsletters, other patient communications *
*  Provider defined
Illustrative Materials
Clear ownership of validated anonymized datasets
Copyrightable
Right to publish
Right to monetize
Illustrative Materials
Not a point solution, but a strategic initiative
Easily extensible and scalable
Accommodates Health Equity initiatives
Accommodates CMS Hospital Value Program and other Value-Based Care initiatives
Clinical Grade
Patented technology
HIPAA, GDPR, GCP and Part 11 compliant
Multilingual
Scalable
Robust reporting functions
Easily export to, integrate with, existing systems
Interested in this Circle?

If you have any questions, please contact us.

ADDITIONAL RESOURCES